Age group | p | |||
---|---|---|---|---|
< 1 y (n = 17) | 1–5 y (n = 3) | 6–12 y (n = 7) | ||
Demographic and clinical characteristics | ||||
Male sex | 10 (58.80%) | 2 (66.70%) | 4 (57.10%) | .960 |
Contact to a positive case | 10 (58.80%) | 2 (66.70%) | 7 (100%) | .132 |
Comorbidity | 7 (41.20%) | 3 (100%) | 6 (85.70%) | .041 |
Fever | 13 (76.50%) | 3 (100%) | 7 (100%) | .251 |
Cough | 7 (41.20%) | 2 (66.70%) | 5 (71.40%) | .446 |
Dyspnea | 6 (35.30%) | 3 (100%) | 6 (85.70%) | .677 |
GIT symptoms | 9 (52.90%) | 1 (33.30%) | 2 (28.60%) | .506 |
DCL | 8 (47.10%) | 2 (66.70%) | 1 (14.30%) | .207 |
Convulsions | 4 (23.50%) | 2 (66.70%) | 1 (14.30%) | .208 |
Shock | 8 (47.10%) | 1 (33.30%) | 1 (14.30%) | .316 |
Laboratory characteristics | ||||
Anemia | 11 (64.70%) | 2 (66.67%) | 4 (57.14%) | .932 |
Thrombocytopenia | 5 (29.4%) | 0 (0.00%) | 1 (14.3%) | .445 |
Leukocytosis | 8 (47.1%) | 3 (100%) | 5 (71.4%) | .170 |
Hypernatremia | 8 (47.1%) | 2 (66.7%) | 4 (57.1%) | .779 |
Hypokalemia | 4 (23.5%) | 1 (33.3%) | 1 (14.3%) | .466 |
Hyperkalemia | 8 (47.1%) | 0 (0.00%) | 2 (28.6%) | |
Hypoxemia | 7 (41.2%) | 2 (66.7%) | 3 (42.9%) | .712 |
Coagulopathy | 7 (41.2%) | 3 (100%) | 3 (42.9%) | .162 |
High d-dimer | 10 (58.8%) | 3 (100%) | 4 (57.1%) | .369 |
High troponin I | 3 (17.65%) | 1 (33.33% | 2 (28.6%) | .87 |
Complications | ||||
AKI | 7 (41.2%) | 1 (33.3%) | 2 (28.6%) | .836 |
Myocarditis | 4 (23.5%) | 1 (33.3%) | 1 (14.3%) | .020 |
Pneumonia | 8 (47.1%) | 3 (100%) | 7 (100%) | .284 |
MIS-C | 5 (29.4%) | 2 (66.7%) | 2 (28.6%) | .430 |
CT findings | ||||
CORADS | ||||
3.00 | 4 (23.5%) | 0 (0.0%) | 0 (0.0%) | .596 |
4.00 | 9 (52.9%) | 2 (66.7%) | 5 (71.4%) | |
5.00 | 4 (23.5%) | 1 (33.3%) | 2 (28.6%) | |
Pneumonia | 4 (23.5%) | 2 (66.7%) | 3 (42.9%) | .284 |
Bilateral findings | 5 (29.4%) | 1 (33.3%) | 2 (28.6%) | .227 |
Cardiomegaly | 11 (64.7%) | 0 (0.0%) | 1 (14.3%) | .02 |